UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
 
FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported):  December 19, 2008
 
NovaMed, Inc. 

(Exact Name of Registrant as Specified in Charter)
 
Delaware
 
0-26625
 
36-4116193
(State or Other Jurisdiction
of incorporation)
 
(Commission 
File Number)
 
(IRS Employer
Identification No.)
         
 
980 North Michigan Avenue, Suite 1620, Chicago, Illinois
 
60611
(Address of Principal Executive Offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code (312) 664-4100

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
 

 
Section 5 – Corporate Governance and Management
 
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Section 409A Amendments

During 2008, the Compensation Committee of the Board of Directors of NovaMed, Inc. (the “Company”) initiated a review of the Company’s employment agreements to ensure compliance with Section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”).

As a result of the foregoing review, on December 19, 2008 the Company amended and restated the employment agreements with Thomas S. Hall, the Company’s President, Chief Executive Officer and Chairman of the Board of Directors, and Scott T. Macomber, Executive Vice President and Chief Financial Officer of the Company.

The Compensation Committee determined to take these actions in order to comply with Section 409A. Each agreement was modified to reflect the provisions of Section 409A, including imposing a six-month delay on distributions upon “separation from service” unless permitted exceptions apply.

Section 9 - Financial Statements and Exhibits
 
Item 9.01
Financial Statements and Exhibits
 
(d) Exhibits
 
 
Exhibit Number
 
Title
       
 
10.1
 
Amended and Restated Employment Agreement dated December 19, 2008 with Thomas S. Hall
       
 
10.2
 
Amended and Restated Employment Agreement dated December 19, 2008 with Scott T. Macomber
 

 
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
NovaMed, Inc.
     
Dated: December 19, 2008
By:  
/s/ Scott T. Macomber  
   
Scott T. Macomber
Executive Vice President and Chief Financial Officer



EXHIBIT INDEX
 
 
Exhibit Number
 
Title
       
 
10.1
 
Amended and Restated Employment Agreement dated December 19, 2008 with Thomas S. Hall
       
 
10.2
 
Amended and Restated Employment Agreement dated December 19, 2008 with Scott T. Macomber